To assess whether β-LATS2−/− might protect against β-cell injury and diabetes, we induced diabetes by multiple-low dose streptozotocin (MLD-STZ) injection in β-LATS2−/−, LATS2fl/fl, and Rip-Cre mice. Here, LATS2 is linked to diabetes mellitus.